Cipla gets USFDA nod for generic product

According to IQVIA (IMS Health), Durezol had US sales of around USD 106 million for the 12-month period ending June 2021.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37A0fLg
via IFTTT

0 comments:

Post a Comment